Form 4: Stepan Co Director Lorinda Burgess Reports Stock Award Acquisition
SEC Form 4 Filing
Director Lorinda Burgess reports acquisition of 2,500 stock awards in Stepan Co.
Summary
- On May 12, 2025, Lorinda Burgess, a director of Stepan Co, acquired 2,500 stock awards.
- These stock awards are payable in shares either following separation from service or after a specified age, as per the director's election.
- Following the transaction, Burgess directly owns 3,927 shares of Stepan Co common stock.
- The price of the derivative security is $54.262.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard regulatory filing detailing stock award acquisition. It doesn't inherently indicate positive or negative performance.
Positives
- The acquisition of stock awards by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The stock awards are deferred and payable in shares pursuant to the director's election either following separation from service or after a specified age.
Industry Context
This is a routine disclosure related to insider transactions, common for publicly traded companies.
Stakeholder Impact
- The acquisition of stock awards by a director may have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 2023/04/24 | Date of execution of Power of Attorney. |
| 2025/05/12 | Date of transaction: acquisition of stock awards. |
| 2025/05/13 | Date of signature of the report. |
Keywords
Form 4, Stepan Co, Director, Stock Awards, Beneficial Ownership, Lorinda Burgess, SCL
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.